The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

A stoppage-time penalty by substitute Gustaf Nilsson secured Club Brugge a 2-1 home win against Atalanta in the first leg of ...

Club Brugge will host Atalanta on Wednesday for the first match of the day in the Champions League league phase playoffs at ...

The following deeds were transferred in Shelby County from Dec. 18-30, 2024: SEC teams are on Monday’s college basketball schedule in two games, including the Kentucky Wildcats squaring off against… ...